Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: Effects on bone mineral density and metabolism
References (30)
- et al.
Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women
Bone
(1990) - et al.
Bone density in premenopausal women, effects of age, dietary intake, physical activity, smoking and birth control pills
Am J Clin Nutr
(1991) Estrogen therapy in the prevention and management of osteoporosis
Am J Obstet Gynecol
(1987)- et al.
The effect of oral contraceptive use on vertebral bone mass in preand post-menopausal women
Contraception
(1986) - et al.
Associations of parity, breast feeding and birth control pills with lumbar spine and femoral neck bone densities
Am J Obstet Gynecol
(1988) - et al.
Long-term contraceptive use does not affect trabecular bone density
Am J Obstet Gynecol
(1989) - et al.
Baseline measurement of bone mass predicts fracture in white women
Ann Int Med
(1989) Attainment of peak bone mass
J Clin Endocrinol Metab
(1990)- et al.
Stochastic models of femoral bone loss and hip fracture risk
- et al.
Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry
J Nucl Med
(1986)
Differential changes in bone mineral density of the appendicular and axial skeleton with ageing
J Clin Invest
Age related bone loss in women evaluated by a single and dual photon technique
Bone Min
The pathophysiology of peri-and postmenopausal bone loss
Br J Obstet Gynaecol
Evaluation of bone density in premenopausal women
Premenopausal bone loss in oligomenorrhoic women: a longitudinal study
Maturitas
Cited by (60)
The combined oral contraceptive pill- recent developments, risks and benefits
2014, Best Practice and Research: Clinical Obstetrics and GynaecologyImpact of oral contraceptive on bone metabolism
2013, Best Practice and Research: Clinical Endocrinology and MetabolismCitation Excerpt :A review paper1 of 13 studies in women using low-dose oral contraceptives reported a positive effect of COC on BMD in 9 studies and 4 studies did not show an association. It is during the late perimenopausal years that the bone effect of COC appears the most relevant in preventing the activation of bone metabolism and the decrease in BMD.2–8 In perimenopausal oligomenorrheic women, the progressive ovarian failure is associated with a decreased production of estradiol which activates bone turnover with a subsequent increase in bone loss.
Hormonal contraception and bone metabolism: A systematic review
2012, ContraceptionCitation Excerpt :Randomized controlled studies are needed to confirm these data. Gambacciani et al. [149–152] performed four randomized prospective studies evaluating BMD at the hip, heel, spine and radius of perimenopausal women treated with COCs. In each study, women experiencing oligomenorrhea were randomized to COCs (20 mcg EE/150 mg desogestrel or 30 mcg EE/75 mg gestodene) or calcium (500 mg/day).
Use of contraceptives for older women
2007, MenopauseUse of Contraceptives for Older Women
2007, Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, Third Edition